Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 1965-1973

  Meshul, Charles K ^a,b,c   Bunker, Gillian L ^a   Mason, John N ^b,c   Allen, Cynthia ^a   Janowsky, Aaron ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Caudate; Clozapine; Glutamate immunolabeling; Haloperidol; MK 801; NMDA

Indexed keywords

CLOZAPINE; DIZOCILPINE; GLUTAMATE RECEPTOR; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SUBCUTANEOUS DRUG ADMINISTRATION; SYNAPSE;

ANIMALIA;

EID: 0029802290     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67051965.x     Document Type: Article

References (46)

1. Arluison M., Dietl M., and Thibault J. (1984) Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: a topographical study. Brain Res. Bull. 13, 269-285.
2. Benes F. M., Paskevich P. A., Davidson J., and Domesick V. B. (1985) The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res. 329, 265-274.
3. Carter L. A., Belknap J. K., Crabbe J. C., and Janowsky A. (1995) Allosteric regulation of the N-methyl-D-aspartate receptor-linked ion channel complex and effects of ethanol in ethanol-withdrawal seizure-prone and -resistant mice. J. Neurochem. 64, 213-219.
4. Casey D. E. (1989) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology (Berlin) 99 (Suppl.), S47-S53.
5. Einot I. and Gabriel K. R. (1975) A study of the powers of several members of multiple comparisons. J. Am. Stat. Assoc. 70, 574-583.
6. Fletcher E. J. and MacDonald J. F. (1993) Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurons. Eur. J. Pharmacol. 235, 291-295.
7. Geinisman Y., Morrell F., and de Toledo-Morrell L. (1988) Remodeling of synaptic architecture during hippocampal "kindling." Proc. Natl. Acad. Sci. USA 85, 3260-3264.
8. Geinisman Y., de Toledo-Morrell L., and Morrell F. (1991) Induction of long-term potentiation is associated with an increase in the number of axospinous synapses with segmented post synaptic densities. Brain Res. 566, 77-88.
9. Greenough W. T., West R. W., and DeVoogd T. J. (1978) Subsynaptic plate perforations: changes with age and experience in the rat. Science 202, 1096-1098.
10. Hepler J. R., Toomim C. S., McCarthy K. D., Conti F., Battaglia G., Rustioni A., and Petrusz P. (1988) Characterization of antisera to glutamate and aspartate. J. Histochem. Cytochem. 36, 13-22.
11. Hollmann M. and Heinemann S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
12. 3H]MK-801 binding to the glutamate receptor - ion channel complex. Schizophr. Res. 2, 189.
13. Janowsky A., Neve K. A., Kinzie J. M., Taylor B., de Paulis T., and Belknap J. K. (1992) Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization, and region-specific regulation by clozapine. J. Pharmacol. Exp. Ther. 261, 1282-1290.
14. Kerns J. M., Sierens D. K., Kao L. C., Klawans H. L., and Carvey P. M. (1992) Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin. Neuropharmacol. 15, 488-500.
15. Kleckner N. W. and Dingledine R. (1988) Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241, 835-837.
16. Lidsky T. I., Yablonsky-Alter E., and Banerjee S. P. (1993) Anti-glutamatergic effects of clozapine. Neurosci. Lett. 163, 155-158.
17. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
18. Luo J. H., Wang Y. H., Yasuda R. P., and Wolfe B. B. (1996) The majority of cortical NMDA receptors contain three subunits (NMDAR1/2A/2B). FASEB J. 10, A141.
19. Meldrum B. (1994) Neuroprotection by NMDA and non-NMDA glutamate antagonists, in Direct and Allosteric Control of Glutamate Receptors (Palfreyman M. G., Reynolds I. J., and Skolnick P., eds), pp. 139-154. CRC Press, Boca Raton, Florida.
20. Meshul C. K. and Casey D. E. (1989) Regional, reversible ultra structural changes in rat brain with chronic neuroleptic treatment. Brain Res. 489, 338-346.
21. Meshul C. K. and Tan S.-E. (1994) Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity. Synapse 18, 205-217.
22. Meshul C. K., Janowsky A., Casey D. E., Stallbaumer R. K., and Taylor B. (1992) Effect of haloperidol and clozapine on the density of 'perforated' synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology (Berlin) 106, 45-52.
23. Meshul C. K., Stallbaumer R. K., Taylor B., and Janowsky A. (1994) Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res. 648, 181-195.
24. Meshul C. K., Buckman J. F., Allen C., Riggan J. P., and Feller D. J. (1996) Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment. Synapse 22, 350-361.
25. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., and Seeburg P. H. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221.
26. Morris R. G. M., Anderson E., Lynch G. S., and Baudry M. (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate antagonist, AP5. Nature 319, 774-776.
27. Nowak G., Trullas R., Layer R. T., Skolnick P., and Paul I. A. (1993) Adaptive changes in the NMDA receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J. Pharmacol Exp. Ther. 265, 1380-1386.
28. 3H] glutamate in synaptic membranes from rat brain. Neurosci. Res. 4, 129-142.
29. Ogita K. and Yoneda Y. (1988) Disclosure by Triton X-100 of NMDA-sensitive [3H] glutamate binding sites in brain synaptic membranes. Biochem. Biophys. Res. Commun. 153, 510-517.
30. Oretti R. G., Spulock G., Buckland P. R., and McGuffin P. (1994) Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains. Neurosci. Lett. 177, 39-43.
31. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, San Diego.
32. Phend K. D., Weinberg R. J., and Rustioni A. (1992) Techniques to optimize post-embedding single and double staining for amino acid neurotransmitters. J. Histochem. Cytochem. 40, 1011-1020.
33. 3H]MK-801 binding to the N-methyl-D-aspartate receptor - ion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 51, 830-836.
34. 3H-Labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc. Natl. Acad. Sci. USA 84, 7744-7748.
35. See R. E. and Chapman M. A. (1994) Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. Eur. J. Pharmacol. 263, 269-276.
36. Simerly R. B., Chang C., Muramatsu M., and Swanson L. W. (1990) Distribution of androgen and estrogen receptor mRNA containing cells in rat brain: an in situ hybridization study. J. Comp. Neurol. 294, 76-95.
37. Sugihara H., Moriyoshi K., Ishii T., Masu M., and Nakanishi S. (1992) Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 185, 826-832.
38. Trevisan L., Fitzgerald L. W., Brose N., Gasic G. P., Heinemann S. F., Duman R. S., and Nestler E. J. (1994) Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. J. Neurochem. 62, 1635-1638.
39. Ulas J., Nguyen L., and Cotman C. W. (1993) Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport 4, 1049-1051.
40. Uranova N. A., Orlovskaya D. D., Apel K., Klintsova A. J., Haselhorst U., and Schenk H. (1991) Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse 7, 253-259.
41. Vincent S. L., McSparren J., Wang R. Y., and Benes F. M. (1991) Evidence for ultrastructural changes in cortical axodendritic synapses following long-term treatment with haloperidol or clozapine. Neuropsychopharmacology 5, 147-155.
42. Wang J. K. T. and Thukral V. (1996) Presynaptic NMDA receptors display physiological characteristics of homomeric complexes of NR1 subunits that contain the exon 5 insert in the N-terminal domain. J. Neurochem. 66, 865-868.
43. Williams K., Dawson V. L., Romano C., Dichter M. A., and Molinoff P. B. (1990) Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron 5, 199-208.
44. Williams K., Hanna J. L., and Molinoff P. B. (1991a) Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. J. Pharmacol. Exp. Ther. 40, 774-782.
45. Williams K., Romano C., Dichter M. A., and Molinoff P. B. (1991b) Modulation of the NMDA receptor by polyamines. Life Sci. 48, 469-498.
46. Yamamoto B. K. and Cooperman M. A. (1994) Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14, 4159-4166.